| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9469 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.8723 |
| P-glycoprotein Substrate | Substrate | 0.7245 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.6446 |
| Inhibitor | 0.6131 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7719 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5918 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8252 |
| CYP450 2D6 Substrate | Non-substrate | 0.8744 |
| CYP450 3A4 Substrate | Substrate | 0.7944 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8907 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9270 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9429 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8107 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8517 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5193 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8189 |
| Non-inhibitor | 0.7523 |
| AMES Toxicity | Non AMES toxic | 0.7963 |
| Carcinogens | Non-carcinogens | 0.9277 |
| Fish Toxicity | High FHMT | 0.9898 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9959 |
| Honey Bee Toxicity | High HBT | 0.8505 |
| Biodegradation | Not ready biodegradable | 0.9871 |
| Acute Oral Toxicity | III | 0.6859 |
| Carcinogenicity (Three-class) | Non-required | 0.5928 |